Extending cervical cancer prevention around the world
While U.S. cervical cancer rates have fallen by 70% since the 1950s thanks to the Pap test and national screening programs, the disease remains a leading killer of women in low- and middle-income countries for lack of access to screening and trained providers.
Kathleen Schmeler, M.D., professor of Gynecologic Oncology and Reproductive Medicine, is working change this. Her work to prevent and treat cervical cancer has taken...
Immunotherapy clinical trial assesses opportunity to prevent lung cancer development, recurrence
An immunotherapy used against advanced non-small cell lung cancer is being tested at MD Anderson for a different...
Moon Shot deploys policy help, education and clinical trial innovation against tobacco use
November is Lung Cancer Awareness Month, and the third Thursday of each November is designated by the American Cancer Society as the Great...
Moon Shot promotes efforts to prevent, quickly detect pancreatic cancer
Each year in the U.S., more than 50,000 people will be diagnosed with pancreatic cancer, which ranks around the 10th most common cancer type. However, it is the third leading cause of cancer death, behind only lung and colorectal cancers.
For Pancreatic Cancer Awareness Month, Cancer Frontline spoke with Anirban Maitra, M.B.B.S., scientific director of the Sheikh Ahmed Pancreatic Cancer Research Center, about important ongoing...
Mutations in tumor-adjacent tissues could reveal earliest events leading to malignancy
MD Anderson researchers have identified early genomic events that may lead to malignant transformation. They’ve found that tissue adjacent...
E-cigarettes: Unstandardized, under-regulated, under-studied – safety unknown
The recent outbreak of lung injury and death associated with e-cigarettes and vaping has led to a renewed scrutiny of electronic nicotine...
Multiple studies show major lack of public knowledge about HPV vaccine and cancer prevention
Despite the fact that the human papillomavirus (HPV) vaccine has been available in the U.S. for over 10 years and remains the only vaccine...
Research finds evidence HPV vaccine is improving herd immunity
A study from researchers at The University of Texas MD Anderson Cancer Center found that the prevalence of the types of oral human papillomavirus...
Moon Shot helps corner aggressive-variant prostate cancer
Prostate cancer is the most common cancer diagnosed in American men, and the second leading cause of cancer death in men. While hormone-based...
$5.1 million grant to expand cervical cancer diagnosis and prevention in Mozambique
MD Anderson Cancer Center researchers, together with collaborators from Mozambique, Brazil and the U.S., have been awarded a $5.1 million...